ABPRO CORP

Profile

Company Names

ABPRO CORP

Addresses

68 CUMMINGS PARK DRIVE, WOBURN, MA 01801

65 CUMMINGS PARK DRIVE, WOBURN, MA 01801

Phone Numbers

617-225-0808

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$42,389,974.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-03-30 
$1,999,998.00 
$80,000,000.00 
$78,000,002.00 
Equity 
3
2020-01-15 
$17,999,992.00 
$40,000,000.00 
$22,000,008.00 
Equity 
2
2017-03-31 
$9,999,990.00 
$29,999,991.00 
$20,000,001.00 
Equity 
1
2016-03-11 
$12,389,994.00 
$20,000,000.00 
$7,610,006.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EUGENE 
 
CHAN 
DIRECTOR, EXECUTIVE OFFICER
IAN 
 
CHAN 
EXECUTIVE OFFICER, DIRECTOR
KEVIN 
 
COMERFORD 
EXECUTIVE OFFICER
BENJAMIN 
 
HA 
DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
ADAM 
S. 
MOSTAFA 
EXECUTIVE OFFICER
SHENGXIN 
 
QIN 
DIRECTOR
MILES 
 
SUK 
DIRECTOR
MILES 
J. 
SUK 
DIRECTOR
MARK 
 
TANG 
DIRECTOR
THOMAS 
 
WENG 
DIRECTOR
FENG 
 
YE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#